Fundamentals Data provided by Morningstar.Data provided by Morningstar.
52 Week Range
Avg. Volume (1 month)
as at 24 Feb 3:44pm
Beaten up ASX cannabis shares showing signs of life
Blazing it? How the top ASX cannabis shares performed in FY21
Why the Ecofibre (ASX:EOF) share price is surging 30% higher this week
Share Market News
Why Brickworks, Ecofibre, Frontier Digital, & Ramsay are storming higher
Why Ecofibre, MoneyMe, Nearmap, & Race Oncology shares are storming higher
Why the Ecofibre (ASX:EOF) share price is soaring 9% higher today
Why Airtasker, Ecofibre, Nuix, & Woolworths shares are sinking
⏸️ ASX Shares
Here are 4 ASX shares that insiders have been buying recently
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
|Date||Announcement||Price Sensitive?||Time||No. of Pages||File Size|
Ecofibre Ltd through its subsidiaries is engaged in three business lines including Ananda Health, Ananda Food and Hemp Black. Amanda Health includes Production and sale of hemp related nutraceutical products focused on the US. Ananda Food includes Production and sale of hemp related food products in Australia. Hemp Black includes the development of hemp related fibreproducts globally.
|10 Aug 2022||$0.30||$0.01||3.45%||17,318||$0.30||$0.30||$0.28|
|09 Aug 2022||$0.29||$0.02||7.27%||3,431||$0.29||$0.29||$0.29|
|08 Aug 2022||$0.28||$0.02||7.84%||62,117||$0.27||$0.28||$0.25|
|05 Aug 2022||$0.26||$-0.04||-13.56%||8,885||$0.30||$0.30||$0.26|
|04 Aug 2022||$0.30||$-0.01||-3.33%||3,151||$0.30||$0.30||$0.30|
|03 Aug 2022||$0.30||$0.01||3.39%||10,252||$0.30||$0.30||$0.30|
|02 Aug 2022||$0.30||$0.00||0.00%||35,000||$0.32||$0.32||$0.30|
|01 Aug 2022||$0.30||$-0.01||-3.28%||5,586||$0.31||$0.31||$0.30|
|29 Jul 2022||$0.31||$0.01||3.33%||82,516||$0.30||$0.31||$0.30|
|28 Jul 2022||$0.30||$0.00||0.00%||102,636||$0.30||$0.30||$0.29|
|27 Jul 2022||$0.30||$0.00||0.00%||25,498||$0.30||$0.30||$0.29|
|26 Jul 2022||$0.30||$0.00||0.00%||52,088||$0.30||$0.30||$0.30|
|25 Jul 2022||$0.30||$0.02||7.02%||15,369||$0.29||$0.30||$0.29|
|22 Jul 2022||$0.29||$0.02||7.41%||43,205||$0.28||$0.30||$0.27|
|21 Jul 2022||$0.27||$0.02||7.84%||1,010||$0.27||$0.27||$0.27|
|20 Jul 2022||$0.26||$0.02||8.33%||68,004||$0.26||$0.30||$0.26|
|19 Jul 2022||$0.24||$0.01||4.26%||40,428||$0.25||$0.25||$0.24|
|18 Jul 2022||$0.24||$0.00||0.00%||88,918||$0.24||$0.24||$0.23|
|15 Jul 2022||$0.24||$0.00||0.00%||10,213||$0.23||$0.24||$0.23|
|14 Jul 2022||$0.23||$0.00||0.00%||20,951||$0.24||$0.24||$0.22|
|13 Jul 2022||$0.23||$0.00||0.00%||22,121||$0.24||$0.24||$0.23|
|12 Jul 2022||$0.23||$0.00||0.00%||20,000||$0.23||$0.23||$0.23|
|04 Mar 2022||Eric Tse Wang||Buy||1||$434,600|| |
|28 Feb 2022||Vanessa Wallace||Buy||250||$101,250|| |
|13 Dec 2021||Bruce Robinson||Buy||30||$16,500|| |
|01 Dec 2021||Jonathan (Jon) Meadmore||Issued||173||$116,379|| |
Issue of options.
|01 Dec 2021||Bruce Robinson||Issued||144||$96,982|| |
Issue of options.
|01 Dec 2021||Kristi Woolrych||Issued||144||$96,982|| |
Issue of options.
|01 Dec 2021||Vanessa Wallace||Issued||386||$258,620|| |
Issue of options.
|Ms Vanessa Miscamble Wallace||Non-Executive Deputy ChairmanNon-Executive Director||Jul 2021|| |
Ms Wallace is an experienced director and has gained experience working as a director of listed and non-listed companies including Wesfarmers Ltd, SEEK Ltd, Doctor Care Anywhere PLC and Palladium Holdings Pty Ltd. Her executive career includes almost 30 years as a strategy management consultant, where she focused on financial services, health and consumer product industries, including co-leading the Booz & Company business in Japan for 4 years. Earlier in her career she was a Portfolio Manager with Investment Bank Schroders. Ms Wallace is an early-stage investor in the health sector and the founding Chairman of Australian digital health & biotechnology business, Drop Bio Pty Ltd.
|Professor Bruce Gregory Robinson||Non-Executive Director||Mar 2021|| |
Prof Robinson has over 25 years leadership experience as a board director, academic physician and scientist across research, healthcare and medicine, and tertiary education. He has experience covering academia, government, public and private health providers, research institutes and philanthropic organisations. He is currently a director of Cochlear, an ASX listed global hearing implants business; MaynePharma, an ASX listed pharmaceutical manufacturer; and QBiotics, a drug development company. Since 2015 Prof Robinson has also chaired the Australian Government's National Health and Medical Research Council, and the Medical Benefits Schedule Review Task Force. His prior professional experience includes Dean of University of Sydney's Sydney Medical School, Head of Medicine at Sydney's Royal North Shore Hospital and Head of the Cancer Genetics Laboratory at the Kolling Institute for Medical Research. The summary of his experience is as follows: 2015 - present: Chair of the National Health and Medical Research Council; 2015 - present: Chair of the Medical Benefits Schedule Review Taskforce; 2007 - 2016: Dean, Sydney Medical School; 1998 - 2006: Head, Division of Medicine, Royal North Shore Hospital; 1990 - 2008: Head, Cancer Genetics Laboratory, Kolling Institute for Medical Research. Boards experience includes : Cochlear, 2015 - present; QBiotics, 2015 - present; MaynePharma, 2014 - present; and Woolcock Institute, 2006 - present.
|Mr Jonathan (Jon) Peter Meadmore||Non-Executive Director||Oct 2017|| |
Mr Meadmore is a Brisbane-based partner of law firm, Colin Biggers & Paisley. He is the joint leader of the corporate group, having practiced law for over 25 years.
|Mr Eric Tse Wang||Chief Executive OfficerManaging Director||Nov 2015|| |
Mr Wang has over 25 years of leadership and executive management experience, both as an officer in the United States Army and as a financial services executive in Australia. Prior to joining Ecofibre, Eric served as Captain and Apache pilot in the US Army for eight years in a range of roles, including Troop Commander, Operations Officer, Executive Officer and Personnel Officer in the United States and Europe.
|Ms Michele Anderson||Non-Executive Director||Mar 2022|| |
Ms Anderson has executive career spans 30 years as an operating business executive, independent director and founder working across the technology, wine and professional services sectors. She has experience across a range of industries in the United States, including leadership of e-commerce and bricks-and-mortar retail businesses. Her leadership contributions in developing and implementing growth strategy, scaling brands and businesses, driving digital growth and transformation, and supporting positive environmental impact and de-carbonisation. She began her career in Australia as a management consultant with Booz Allen and Hamilton and then spent most of her career to date working in the US, including running Shutterfly's consumer ecommerce business in Silicon Valley and Staples' Print and Marketing Services business. Michele also has experience founding and scaling businesses in the highly regulated wine and alcoholic beverages industry. She is an independent director of one of the wine businesses, Baron Philippe de Rothschild, SA.
|Mr Jonathan Cedric Mengel Brown||Chief Financial OfficerCompany Secretary||Jan 2021|| |
|Ms Robin Sheldon||General CounselJoint Company Secretary||Jan 2021|| |
|Jonathan Cedric Mengel Brown||Chief Financial OfficerCompany Secretary|| |
|Robin Sheldon||General CounselJoint Company Secretary|| |
|Barjoy Pty Ltd||37,688,454||11.05%|
|Barry Martin Lambert & Joy Wilma Lillian Lambert||34,497,242||10.12%|
|Phil Warner Pty Ltd||32,481,381||9.52%|
|HSBC Custody Nominees (Australia) Limited||25,820,376||7.57%|
|Freshwater Superannuation Fund Pty Limited||20,089,149||5.89%|
|Kylie Warner Pty Ltd||16,340,072||4.79%|
|Thomas Jefferson University||12,178,259||3.57%|
|Citicorp Nominees Pty Limited||7,664,587||2.25%|
|Pacific Custodians Pty Limited (Employee Securities Tst Unallocated A/C)||7,200,000||2.11%|
|Pacific Custodians Pty Limited (Employee Securities Tst A/C)||6,909,286||2.03%|
|Wow Corporate Pty Ltd||6,648,700||1.95%|
|Manderrah Pty Limited||5,243,369||1.54%|
|Walling Pty Limited||4,850,181||1.42%|
|National Nominees Limited||3,163,706||0.93%|
|Yarrawonga Holdings Pty Limited (Yarrawonga Super Fund A/C)||3,048,553||0.89%|
|Troncell Pty Ltd||2,922,078||0.86%|